viraleze???? 2.50?? based on what??
that product has cost 10-20mil + to develop and market and the company has nothing to show for it.
market has lost fauth in the ability of this company to commercialise anything - quite clear - look at the recent rise from positive DEP results
equivalent data back in the day in 2015 etc would have scored a 20% share price rise which is now 5%
Ann: Positive final DEP irinotecan Phase 2 clinical trial results, page-41
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
